Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 4/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL6948482 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Hexane SCHEMBL6948245 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Hexane SCHEMBL260348 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Heptane SCHEMBL2706852 | 0.96 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Hexane SCHEMBL7315287 | 0.95 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Hexane SCHEMBL3003669 | 0.95 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Hexane SCHEMBL6415173 | 0.95 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Ethyl Acetate SCHEMBL6986234 | 0.93 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Heptane SCHEMBL9865847 | 0.93 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10FAAHMEN1 | |
| Heptane SCHEMBL11904142 | 0.93 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10FAAHMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109761826-B | O-desmethylvenlafaxine phenyl ether compound and preparation method and application thereof | 烟台大学 | 2022-02-25 | — | — | CN | claimed |
| CN-109761826-A | A kind of O-DMV phenylate compound and its preparation method and application | 烟台大学 | 2019-05-17 | — | — | CN | claimed |
| EP-4245369-A2 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | Sage Therapeutics, Inc. (US) | 2023-09-20 | — | — | EP | disclosed |
| US-20230192756-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | Sage Therapeutics, LLC | 2023-06-22 | — | — | US | disclosed |
| EP-2753632-B1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SAGE THERAPEUTICS INC (US) | 2023-05-10 | — | — | EP | disclosed |
| US-11345682-B2 | Polymorph of HDAC6-selective inhibitor and application thereof | CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD. (CN) | 2022-05-31 | — | — | US | disclosed |
| CN-109761826-B | O-desmethylvenlafaxine phenyl ether compound and preparation method and application thereof | 烟台大学 | 2022-02-25 | — | — | CN | disclosed |
| EP-3865135-A2 | NEUROACTIVE STEROIDS FOR USE IN THERAPY | Sage Therapeutics, Inc. (US) | 2021-08-18 | — | — | EP | disclosed |
| US-20210147394-A1 | POLYMORPH OF HDAC6-SELECTIVE INHIBITOR AND APPLICATION THEREOF | CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD. (CN) | 2021-05-20 | — | — | US | disclosed |
| US-20210147470-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SAGE THERAPEUTICS, INC. | 2021-05-20 | — | — | US | disclosed |
| US-10759828-B2 | Neuroactive steroids, compositions, and uses thereof | SAGE THERAPEUTICS, INC. (US) | 2020-09-01 | — | — | US | disclosed |
| EP-0684514-A1 | Tight-wrapped photographic element containing a high dye-yield coupler | EASTMAN KODAK COMPANY (US) | 1995-11-29 | — | — | EP | disclosed |
| EP-0684516-A1 | Photographic element containing a high dye-yield coupler with a methine dye chromophore | EASTMAN KODAK COMPANY (US) | 1995-11-29 | — | — | EP | disclosed |
| EP-0684517-A1 | Photographic element with silver halide emulsion layer of low developability and having an associated high dye-yield coupler | EASTMAN KODAK COMPANY (US) | 1995-11-29 | — | — | EP | disclosed |
| US-5470688-A | Heat development of elements containing methine-dye releasing couplers | EASTMAN KODAK COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| US-5457004-A | Exposure the element, comprising a substrate and a photographic silver halide emulsion layer associated with high yield coupler, with oxidized color developer forming an image | EASTMAN KODAK COMPANY (US) | 1995-10-10 | — | — | US | disclosed |
| US-5455140-A | Image quality, preferred hues | EASTMAN KODAK COMPANY (US) | 1995-10-03 | — | — | US | disclosed |
| US-5447819-A | Photographic element containing high dye-yield couplers having improved reactivity | EASTMAN KODAK COMPANY (US) | 1995-09-05 | — | — | US | disclosed |
| US-5246820-A | Precursor which hydrolyzes than decomposes to carbon dioxide and non-diffusable amine | EASTMAN KODAK COMPANY | 1993-09-21 | — | — | US | disclosed |
| EP-0560424-A1 | Carbamic acid solubilized smearing couplers | EASTMAN KODAK COMPANY (US) | 1993-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345682-B2 | Polymorph of HDAC6-selective inhibitor and application thereof | HDAC6, HDAC1, HDAC3 | ALDH1A1 317/4885LMNA 2498/4885HSD17B10 377/4885 |
| US-20210147470-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | CHRNB4, CHRNB3, MC2R | ALDH1A1 1088/4885LMNA 2320/4885HSD17B10 923/4885 |
| US-10759828-B2 | Neuroactive steroids, compositions, and uses thereof | CHRNB4, CHRNB3, MC2R | ALDH1A1 1088/4885LMNA 2320/4885HSD17B10 923/4885 |
| US-20210147394-A1 | POLYMORPH OF HDAC6-SELECTIVE INHIBITOR AND APPLICATION THEREOF | HDAC6, HDAC1, HDAC3 | ALDH1A1 317/4885LMNA 2498/4885HSD17B10 377/4885 |
| US-20230192756-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | CHRNB4, CHRNB3, MC2R | ALDH1A1 1160/4885LMNA 2338/4885HSD17B10 970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.